Peanut allergy treatment to ‘reset’ the immune system
Human clinical trials of a world-first peanut allergy treatment will begin in Melbourne in June 2017, with researchers focussing on the molecular parts of the potent nut allergen that are needed to build tolerance, while removing the risk of a severe reaction. The research has been supported by the Australian Food Allergy Foundation, Gandel Foundation, the Alfred Hospital Trust, and the National Health and Medical Research Council.